QQ客服 官方微博 反馈留言

	Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors.
	Huang, Jing; Mo, Hongnan; Wu, Dawei; Chen, Xuelian; Ma, Lanying; Lan, Bo; Qu, Dong; Yang, Qing; Xu, Binghe
	2017
卷号	35
ISSN号	0732-183X
DOI	10.1200/JCO.2017.35.15_suppl.e15572
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6369374
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Huang, Jing,Mo, Hongnan,Wu, Dawei,et al. Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors.[J],2017,35.
APA	Huang, Jing.,Mo, Hongnan.,Wu, Dawei.,Chen, Xuelian.,Ma, Lanying.,...&Xu, Binghe.(2017).Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors..,35.
MLA	Huang, Jing,et al."Phase I study of the anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors.".35(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。